M. Jendro

发表

Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-α in vitro

H. Zeidler, L. Köhler, A. Liese, 2004, Medical Microbiology and Immunology.

Microarrays demystified.

U. Müller-Ladner, F. Stenner, S. Bauer, 2004, Environmental health perspectives.

Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis

H. Zeidler, J. Lotz, E. Raum, 2004, Annals of the rheumatic diseases.

Cytokine profile in serum and synovial fluid of arthritis patients with Chlamydia trachomatis infection

H. Zeidler, L. Köhler, E. Raum, 2003, Rheumatology International.

Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study.

H. Zeidler, J. Wollenhaupt, J. Kuipers, 2001, Arthritis and rheumatism.

Tuberculosis cutis colliquativa during long-term immunosuppressive therapy for rheumatoid arthritis.

J. Ockenga, P. Kirschner, M. Mendila, 1997, Arthritis and rheumatism.

Microbe-induced T cell apoptosis: subversion of the host defense system?

H. Zeidler, L. Köhler, J. Kuipers, 2002, FEMS microbiology letters.

Antibiotic treatment of Lyme borreliosis: what is the evidence?

H. Zeidler, R. Dinser, M. Jendro, 2005, Annals of the rheumatic diseases.

Infection of Human Monocyte-Derived Macrophages with Chlamydia trachomatis Induces Apoptosis of T Cells: a Potential Mechanism for Persistent Infection

B. Krausse-Opatz, H. Zeidler, L. Köhler, 2000, Infection and Immunity.

Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome.

H. Zeidler, J. Hülsemann, J. Andresen, 2002, Arthritis and rheumatism.

Increased titres of anti‐nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms

R. Dinser, A. Engel, M. Jendro, 2007, Scandinavian journal of rheumatology.

Improvement of Erdheim–Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil

A. Schwarz, H. Zeidler, H. Haller, 2004, Clinical Rheumatology.

Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders.

J. Goronzy, C. Weyand, M. Jendro, 1991, Autoimmunity.

Structural and functional characterization of HLA-DR molecules circulating in the serum.

C. Weyand, J. Goronzy, C. Weyand, 1991, Autoimmunity.

Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis.

E. Matteson, C. Weyand, J. Goronzy, 1995, Arthritis and rheumatism.

Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

C. Weyand, J. Goronzy, P. Bartz-Bazzanella, 1994, The Journal of clinical investigation.

Multiple Mechanisms Support Oligoclonal T Cell Expansion in Rheumatoid Synovitis

H. Rittner, A. Zettl, C. Weyand, 1997, Molecular medicine.

The modulation of chlamydial replication by HLA-B27 depends on the cytoplasmic domain of HLA-B27.

H. Zeidler, M. Ikeda, D. Yu, 2001, Clinical and experimental rheumatology.

The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes.

E. Märker-Hermann, H. Zeidler, M. Ikeda, 2002, Clinical and Experimental Rheumatology.

group data base Scleroderma Trials And Research (EUSTAR) in systemic sclerosis - a report from the EULAR Clinical risk assessment of organ manifestations

Gianluigi, Wigley, A. Gabrielli, 2007 .